Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial

Douglas Adkins; Jessica Ley; Prakash Neupane; Francis Worden; Assuntina G. Sacco; Kevin Palka; Juneko E. Grilley-Olson; Ronald Maggiore; Noha N. Salama; Kathryn Trinkaus; Brian A. Van Tine; Conor E. Steuer; Nabil F. Saba; Peter Oppelt

doi:10.1016/S1470-2045(19)30405-X

Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial

Douglas Adkins, Jessica Ley, Prakash Neupane, Francis Worden, Assuntina G. Sacco, Kevin Palka, Juneko E. Grilley-Olson, Ronald Maggiore, Noha N. Salama, Kathryn Trinkaus, Brian A. Van Tine, Conor E. Steuer, Nabil F. Saba, Peter Oppelt

Pharmaceutical and Administrative Sciences Department

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1295-1305
Number of pages	11
Journal	The Lancet Oncology
Volume	20
Issue number	9
DOIs	https://doi.org/10.1016/S1470-2045(19)30405-X
State	Published - Sep 2019

ASJC Scopus Subject Areas

Oncology

Access to Document

10.1016/S1470-2045(19)30405-X

Cite this

Adkins, D., Ley, J., Neupane, P., Worden, F., Sacco, A. G., Palka, K., Grilley-Olson, J. E., Maggiore, R., Salama, N. N., Trinkaus, K., Van Tine, B. A., Steuer, C. E., Saba, N. F., & Oppelt, P. (2019). Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial. The Lancet Oncology, 20(9), 1295-1305. https://doi.org/10.1016/S1470-2045(19)30405-X

Adkins, D, Ley, J, Neupane, P, Worden, F, Sacco, AG, Palka, K, Grilley-Olson, JE, Maggiore, R, Salama, NN, Trinkaus, K, Van Tine, BA, Steuer, CE, Saba, NF & Oppelt, P 2019, 'Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial', The Lancet Oncology, vol. 20, no. 9, pp. 1295-1305. https://doi.org/10.1016/S1470-2045(19)30405-X

@article{69617adba9c24f9898b5f65cefae0e13,

title = "Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial",

author = "Douglas Adkins and Jessica Ley and Prakash Neupane and Francis Worden and Sacco, {Assuntina G.} and Kevin Palka and Grilley-Olson, {Juneko E.} and Ronald Maggiore and Salama, {Noha N.} and Kathryn Trinkaus and {Van Tine}, {Brian A.} and Steuer, {Conor E.} and Saba, {Nabil F.} and Peter Oppelt",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Ltd",

year = "2019",

month = sep,

doi = "10.1016/S1470-2045(19)30405-X",

language = "English",

volume = "20",

pages = "1295--1305",

journal = "The Lancet Oncology",

issn = "1470-2045",

number = "9",

}

TY - JOUR

T1 - Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer

T2 - a multicentre, multigroup, phase 2 trial

AU - Adkins, Douglas

AU - Ley, Jessica

AU - Neupane, Prakash

AU - Worden, Francis

AU - Sacco, Assuntina G.

AU - Palka, Kevin

AU - Grilley-Olson, Juneko E.

AU - Maggiore, Ronald

AU - Salama, Noha N.

AU - Trinkaus, Kathryn

AU - Van Tine, Brian A.

AU - Steuer, Conor E.

AU - Saba, Nabil F.

AU - Oppelt, Peter

PY - 2019/9

Y1 - 2019/9

UR - http://www.scopus.com/inward/record.url?scp=85071533195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071533195&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(19)30405-X

DO - 10.1016/S1470-2045(19)30405-X

M3 - Article

C2 - 31351869

AN - SCOPUS:85071533195

SN - 1470-2045

VL - 20

SP - 1295

EP - 1305

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 9

ER -

Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this